Health Department moves to calm fears over medicine shortages, packaging changes

The South African Health Department has taken steps to allay public concerns over potential medicine shortages and changes in medication packaging. In a statement, department spokesperson Foster Mohale clarified that such alterations in appearance should not signal a lack of treatment or changes in medication efficacy. Mohale emphasized that a shift in color, shape, packaging, or manufacturer does not imply a change in the actual medicine.

The department explained that public healthcare facilities draw medicines from various approved suppliers adhering to stringent regulatory and quality standards. Consequently, patients may receive drugs from different manufacturers, leading to variations in appearance. Yet, Mohale reassured that these differences do not impact therapeutic benefits, as the medicines retain the same active ingredients and are approved as interchangeable.

Health authorities further highlighted that healthcare professionals, including doctors, pharmacists, and nurses, are empowered to dispense equivalent medicines, ensuring uninterrupted treatment for patients. For those uncertain about medication changes, the department advised seeking advice from healthcare professionals.

Addressing specific concerns about medicine shortages, Mohale stressed that reports of stock shortages do not equate to patients being denied treatment. Instead, shortages often pertain to a particular brand, supplier, or pack size, not the medicine itself. He noted that in many instances, an equivalent medicine remains accessible, enabling healthcare workers to provide clinically appropriate alternatives, thus maintaining continuity of care.

The Health Department acknowledged the vulnerability of medicine supply chains to international disruptions, such as manufacturing delays, raw material shortages, heightened global demand, and transport issues. While South Africa, like other nations, faces these challenges, the department remains proactive in minimizing disruptions and ensuring access to essential medicines.

To enhance oversight of medicine availability, the Health Department continuously monitors stock levels using the National Surveillance Centre and the Stock Visibility System (SVS), a digital monitoring tool. These systems offer early warnings of potential supply issues and facilitate collaboration among provinces, facilities, suppliers, and regulators to address risks preemptively.

Mohale reiterated the Health Department's commitment to ensuring South Africans continue receiving "safe, effective, and quality-assured medicines" through the public health system.